Brain metastases from HER2-positive breast cancer

The Lancet Oncology

Volumn 14, Issue 1, 2013, Pages

  Susheela, Sridhar Papaiah ^a   Revannasiddaiah, Swaroop ^a   Madhusudhan, N ^a   Basavalingaiah, Ajaikumar ^a  

^a Bangalore Institute of Oncology   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; LAPATINIB; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL; QUINAZOLINE DERIVATIVE;

BRAIN METASTASIS; BRAIN RADIATION; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; DERMATITIS; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; HAND FOOT SYNDROME; HUMAN; LETTER; PRIORITY JOURNAL; STEREOTACTIC RADIOSURGERY; BRAIN TUMOR; BREAST TUMOR; FEMALE; NOTE;

BRAIN NEOPLASMS; BREAST NEOPLASMS; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; QUINAZOLINES;

EID: 84871822637     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70557-0     Document Type: Letter

References (5)

1. Bachelot T, Romieu G, Campone M, et al. Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study. Lancet Oncol 2013, 14:64-71.
2. Webster-Gandy JD, How C, Harrold K Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre. Eur J Oncol Nurs 2007, 11:238-246.
3. Walko CM, Lindley C Capecitabine: a review. Clin Ther 2005, 27:23-44.
4. Moy B, Goss PE Lapatinib-associated toxicity and practical management recommendations. Oncologist 2007, 12:756-765.
5. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999, 45:427-434.